vs
AerSale Corp（ASLE）とNATURES SUNSHINE PRODUCTS INC（NATR）の財務データ比較。上の社名をクリックして会社を切り替えられます
NATURES SUNSHINE PRODUCTS INCの直近四半期売上が大きい（$123.8M vs $90.9M、AerSale Corpの約1.4倍）。AerSale Corpの純利益率が高く（5.9% vs 3.3%、差は2.6%）。NATURES SUNSHINE PRODUCTS INCの前年同期比売上増加率が高い（4.7% vs -4.0%）。AerSale Corpの直近四半期フリーキャッシュフローが多い（$9.8M vs $7.6M）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs 0.2%）
AerSale Corpはアメリカ合衆国フロリダ州ドラールを本拠とする航空分野のグローバルサプライヤーです。旅客・貨物航空会社、政府機関、多国籍航空機メーカー、独立系MRO事業者に対し、中古の民間ジェット旅客機、エンジン、航空用部材を供給するほか、航空工学サービスも提供しており、航空機 fleet リサイクル協会の会員でもあります。
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
ASLE vs NATR — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $90.9M | $123.8M |
| 純利益 | $5.4M | $4.1M |
| 粗利率 | 34.1% | 72.5% |
| 営業利益率 | 7.8% | 4.3% |
| 純利益率 | 5.9% | 3.3% |
| 売上前年比 | -4.0% | 4.7% |
| 純利益前年比 | 99.7% | 1379.4% |
| EPS（希薄化後） | $0.10 | $0.23 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $90.9M | $123.8M | ||
| Q3 25 | $71.2M | $128.3M | ||
| Q2 25 | $107.4M | $114.8M | ||
| Q1 25 | $65.8M | $113.2M | ||
| Q4 24 | $94.7M | $118.2M | ||
| Q3 24 | $82.7M | $114.6M | ||
| Q2 24 | $77.1M | $110.6M | ||
| Q1 24 | $90.5M | $111.0M |
| Q4 25 | $5.4M | $4.1M | ||
| Q3 25 | $-120.0K | $5.3M | ||
| Q2 25 | $8.6M | $5.3M | ||
| Q1 25 | $-5.3M | $4.7M | ||
| Q4 24 | $2.7M | $-321.0K | ||
| Q3 24 | $509.0K | $4.3M | ||
| Q2 24 | $-3.6M | $1.3M | ||
| Q1 24 | $6.3M | $2.3M |
| Q4 25 | 34.1% | 72.5% | ||
| Q3 25 | 30.2% | 73.3% | ||
| Q2 25 | 32.9% | 71.7% | ||
| Q1 25 | 27.3% | 72.1% | ||
| Q4 24 | 31.4% | 72.0% | ||
| Q3 24 | 28.6% | 71.3% | ||
| Q2 24 | 28.2% | 71.4% | ||
| Q1 24 | 31.8% | 71.2% |
| Q4 25 | 7.8% | 4.3% | ||
| Q3 25 | 4.0% | 7.0% | ||
| Q2 25 | 11.7% | 3.7% | ||
| Q1 25 | -10.1% | 5.4% | ||
| Q4 24 | 5.2% | 3.8% | ||
| Q3 24 | 2.4% | 4.6% | ||
| Q2 24 | -2.4% | 5.1% | ||
| Q1 24 | 5.2% | 4.2% |
| Q4 25 | 5.9% | 3.3% | ||
| Q3 25 | -0.2% | 4.2% | ||
| Q2 25 | 8.0% | 4.6% | ||
| Q1 25 | -8.0% | 4.2% | ||
| Q4 24 | 2.9% | -0.3% | ||
| Q3 24 | 0.6% | 3.8% | ||
| Q2 24 | -4.7% | 1.2% | ||
| Q1 24 | 6.9% | 2.1% |
| Q4 25 | $0.10 | $0.23 | ||
| Q3 25 | $0.00 | $0.30 | ||
| Q2 25 | $0.18 | $0.28 | ||
| Q1 25 | $-0.10 | $0.25 | ||
| Q4 24 | $0.05 | $-0.02 | ||
| Q3 24 | $0.01 | $0.23 | ||
| Q2 24 | $-0.07 | $0.07 | ||
| Q1 24 | $0.12 | $0.12 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $4.4M | $93.9M |
| 総負債低いほど良い | $1.3M | — |
| 株主資本純資産 | $424.4M | $161.6M |
| 総資産 | $640.5M | $261.1M |
| 負債/資本比率低いほどレバレッジが低い | 0.00× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $4.4M | $93.9M | ||
| Q3 25 | $5.3M | $95.6M | ||
| Q2 25 | $5.7M | $81.3M | ||
| Q1 25 | $4.7M | $86.5M | ||
| Q4 24 | $4.7M | $84.7M | ||
| Q3 24 | $9.8M | $78.7M | ||
| Q2 24 | $4.3M | $68.7M | ||
| Q1 24 | $2.6M | $77.8M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | $2.1M |
| Q4 25 | $424.4M | $161.6M | ||
| Q3 25 | $417.1M | $166.7M | ||
| Q2 25 | $415.9M | $163.7M | ||
| Q1 25 | $406.5M | $167.1M | ||
| Q4 24 | $455.6M | $161.0M | ||
| Q3 24 | $451.5M | $162.6M | ||
| Q2 24 | $449.8M | $156.4M | ||
| Q1 24 | $452.0M | $159.7M |
| Q4 25 | $640.5M | $261.1M | ||
| Q3 25 | $646.3M | $264.8M | ||
| Q2 25 | $646.7M | $254.9M | ||
| Q1 25 | $646.1M | $252.7M | ||
| Q4 24 | $604.7M | $240.9M | ||
| Q3 24 | $601.5M | $245.3M | ||
| Q2 24 | $598.7M | $235.8M | ||
| Q1 24 | $571.7M | $247.3M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | 0.01× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $11.4M | $9.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $9.8M | $7.6M |
| FCFマージンFCF / 売上 | 10.8% | 6.1% |
| 設備投資強度設備投資 / 売上 | 1.7% | 1.9% |
| キャッシュ転換率営業CF / 純利益 | 2.11× | 2.41× |
| 直近12ヶ月FCF直近4四半期 | $-29.1M | $28.8M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $11.4M | $9.9M | ||
| Q3 25 | $-8.9M | $18.5M | ||
| Q2 25 | $19.8M | $4.3M | ||
| Q1 25 | $-45.2M | $2.6M | ||
| Q4 24 | $37.5M | $12.2M | ||
| Q3 24 | $10.4M | $9.6M | ||
| Q2 24 | $-15.3M | $1.3M | ||
| Q1 24 | $-21.5M | $2.2M |
| Q4 25 | $9.8M | $7.6M | ||
| Q3 25 | $-9.8M | $16.8M | ||
| Q2 25 | $18.6M | $3.0M | ||
| Q1 25 | $-47.6M | $1.5M | ||
| Q4 24 | $32.3M | $10.0M | ||
| Q3 24 | $8.9M | $7.9M | ||
| Q2 24 | $-18.9M | $-2.0M | ||
| Q1 24 | $-25.0M | $-1.5M |
| Q4 25 | 10.8% | 6.1% | ||
| Q3 25 | -13.8% | 13.1% | ||
| Q2 25 | 17.3% | 2.6% | ||
| Q1 25 | -72.4% | 1.3% | ||
| Q4 24 | 34.0% | 8.5% | ||
| Q3 24 | 10.7% | 6.9% | ||
| Q2 24 | -24.6% | -1.9% | ||
| Q1 24 | -27.7% | -1.4% |
| Q4 25 | 1.7% | 1.9% | ||
| Q3 25 | 1.3% | 1.3% | ||
| Q2 25 | 1.1% | 1.2% | ||
| Q1 25 | 3.7% | 1.0% | ||
| Q4 24 | 5.6% | 1.9% | ||
| Q3 24 | 1.9% | 1.5% | ||
| Q2 24 | 4.7% | 3.0% | ||
| Q1 24 | 3.9% | 3.3% |
| Q4 25 | 2.11× | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | 2.31× | 0.81× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | -3.42× | 0.94× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
